Biotech's 2004 IPOs: Better Rewards for VCs?
This article was originally published in Start Up
Executive Summary
The biotech IPO window cracked open slightly last year for seven companies with manageable step-ups-but will the market be more receptive in 2004 to firms seeking bigger windfalls?